← Companies|ArriVent BioPharma
AV

ArriVent BioPharma

AVBP·NASDAQNew Haven CTFounded 201980 employees
Small CapbiotechPublicOncology
Platform: China-US Bridge
Market Cap
$1.2B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (AVBP)
Loading AVBP stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ZorinesiranAVB-9238Phase 2/32MultispecificJAK2GLP-1/GIPPompeCLL
AVB-7847AVB-7847Phase 1/21PeptideC5FGFRiIPFLGS
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)
2026-08-04
Zorinesiran Fast Track
Pompe
Fast Track
2029-09-12
Zorinesiran Ph3 Readout
CLL
Ph3 Readout
2031-11-06
Zorinesiran Ph3 Readout
Pompe
Ph3 Readout